Collegium Pharmaceutical Inc (COLL)
Stock-Based Compensation
$14.48M
Quarterly · Period ending: · USD
COLL Stock-Based Compensation
Latest reported$14.48Mperiod ending
Latest reported$14.48Mperiod ending
COLL Quarterly Stock-Based Comp ($5.00K → $14.48M)
Quarterly stock-based compensation
High-resolution chart · PNG
COLL stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 14,484,000 | |
| 10,880,000 | |
| 9,753,000 | |
| 9,811,000 | |
| 10,818,000 | |
| 11,524,000 | |
| 7,596,000 | |
| 7,317,000 | |
| 10,012,000 | |
| 7,475,000 | |
| 7,002,000 | |
| 7,027,000 | |
| 7,072,000 | |
| 6,035,000 | |
| 5,670,000 | |
| 5,377,000 | |
| 5,692,000 | |
| 6,135,000 | |
| 4,912,000 | |
| 5,948,000 | |
| 6,516,000 | |
| 6,879,000 | |
| 6,210,000 | |
| 5,165,000 | |
| 0 | |
| 4,951,000 | |
| 3,966,000 | |
| 4,137,000 | |
| 4,162,000 | |
| 4,263,000 | |
| 3,598,000 | |
| 3,926,000 | |
| 3,526,000 | |
| 2,728,000 | |
| 2,078,000 | |
| 2,100,000 | |
| 1,946,000 | |
| 1,821,000 | |
| 1,650,000 | |
| 1,641,000 | |
| 1,395,000 | |
| 1,101,000 | |
| 992,000 | |
| 503,000 | |
| 601,000 | |
| 113,000 | |
| 6,000 | |
| 5,000 | |
| 6,000 | |
| 5,000 |